Leukemia and Lymphoma Society of Canada and Cancer Research Society: 2025 Operating Grant for Blood Cancer Research
Sponsor
Leukemia and Lymphoma Society of Canada (LLSC) and the Cancer Research Society (CRS)
For More Information
For additional information, please see the Operating Grant:
- Program Guidelines & Instructions [1]
- Program Policies & Procedures [2]
Description
The Operating Grant is a two-year grant designed to provide funding to research that may ultimately lead to a significant change in the understanding, diagnosis, or treatment of blood cancer. The LLSC is pleased to continue our partnership with the Cancer Research Society (CRS) to co-fund five (5) Operating Grants in this funding cycle. The CRS is a national not-for-profit organization whose sole mission is to fund research on all types of cancer, thereby contributing to the advancement of science aimed at preventing, detecting, and treating the disease.
Funding Availability
The Operating Grant will provide funding up to a maximum of $100,000 per year for two years (up to a maximum total of $200,000 for the two years).
Indirect Costs
0% per guidelines
Deadlines
If College-level review is required, your College will communicate its earlier internal deadlines.
| Type | Date | Notes |
|---|---|---|
External Deadline | Letter of Intent: Mandatory: Applicant to submit LOI directly to the sponsor via ProposalCentral [3]. | |
Internal Deadline | Application, if invited: Applicant to submit a copy of the application and signed signature page along with complete OR-5 form to: research.services@uoguelph.ca [4] | |
External Deadline | Application, if invited: All application processes must be completed using the ProposalCentral grants management website [5]. |